Personensuche
Personensuche
Es wurde 1 Person gefunden.
Institut für Medizinische Mikrobiologie am Universitätsklinikum Essen
Anschrift
Hufelandstr. 55
45122 Essen
45122 Essen
Telefon
E-Mail
Funktionen
-
Wiss. Mitarbeiter/in und Wiss. Assistent/in, Institut für Medizinische Mikrobiologie
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
Keine vergangenen Veranstaltungen.
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Thyroid hormone receptor α signaling shapes innate and adaptive immune responses during viral infectionIn: European Thyroid Journal, 2025, in pressDOI (Open Access)
-
Influenza virus infection enhances tumour-specific CD8+ T-cell immunity, facilitating tumour controlIn: PLoS Pathogens, Jg. 20, 2024, Nr. 1, e1011982DOI (Open Access)
-
Bacteria (E. coli) take up ultrasmall gold nanoparticles (2 nm) as shown by different optical microscopic techniques (CLSM, SIM, STORM)In: Nano Select, Jg. 3, 2022, Nr. 10, S. 1407 – 1420DOI, Online Volltext (Open Access)
-
CD47 restricts antiviral function of alveolar macrophages during influenza virus infectionIn: iScience, Jg. 25, 2022, Nr. 12, 105540DOI (Open Access)
-
Immunotherapy With Interferon α11, But Not Interferon Beta, Controls Persistent Retroviral InfectionIn: Frontiers in Immunology, Jg. 12, 2022, 809774DOI, Online Volltext (Open Access)
-
A combination of anti-pd-l1 treatment and therapeutic vaccination facilitates improved retroviral clearance via reactivation of highly exhausted t cellsIn: mBio, Jg. 12, 2021, Nr. 1, S. e02121 – 20DOI (Open Access)
-
Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathologyIn: PLoS Pathogens, Jg. 16, 2020, Nr. 3, e1008340DOI (Open Access)
-
Effective Activation of Human Antigen-Presenting Cells and Cytotoxic CD8+ T Cells by a Calcium Phosphate-Based Nanoparticle Vaccine Delivery SystemIn: Vaccines, Jg. 8, 2020, Nr. 1, 110DOI, Online Volltext (Open Access)
-
In vivo biodistribution of calcium phosphate nanoparticles after intravascular, intramuscular, intratumoral, and soft tissue administration in mice investigated by small animal PET/CTIn: Acta Biomaterialia, Jg. 109, 2020, S. 244 – 253
-
Influenzavirus - gefährliche Wandlungsfähigkeit : Hürden bei der Impfstoffentwicklung und die Rolle des angeborenen Immunsystems als alternativer Ansatzpunkt für neue TherapienIn: Unikate: Berichte aus Forschung und Lehre, 2020, Nr. 54: Medizin: Infektionskrankheiten - ein globales Problem, S. 8 – 17DOI, Online Volltext (Open Access)
-
A tumor-peptide–based nanoparticle vaccine elicits efficient tumor growth control in antitumor immunotherapyIn: Molecular Cancer Therapeutics, Jg. 18, 2019, Nr. 6, S. 1069 – 1080DOI (Open Access)
-
A systematic electron microscopic study on the uptake of barium sulphate nano-, submicro-, microparticles by bone marrow-derived phagocytosing cellsIn: Acta Biomaterialia, Jg. 80, 2018, S. 352 – 363
-
Induction of Type I Interferons by Therapeutic Nanoparticle-Based Vaccination Is Indispensable to Reinforce Cytotoxic CD8+ T Cell Responses During Chronic Retroviral InfectionIn: Frontiers in Immunology, Jg. 9, 2018, 614DOI (Open Access)
-
Avidin-conjugated calcium phosphate nanoparticles as a modular targeting system for the attachment of biotinylated molecules in vitro and in vivoIn: Acta Biomaterialia, Jg. 57, 2017, S. 414 – 425
-
Delivery of the TLR ligand poly(I:C) to liver cells in vitro and in vivo by calcium phosphate nanoparticles leads to a pronounced immunostimulationIn: Acta Biomaterialia, Jg. 64, 2017, S. 401 – 410
-
Local delivery of siRNA-loaded calcium phosphate nanoparticles abates pulmonary inflammationIn: Nanomedicine: Nanotechnology, Biology, and Medicine, Jg. 13, 2017, Nr. 8, S. 2395 – 2403
-
Combination of nanoparticle‑based therapeutic vaccination and transient ablation of regulatory T cells enhances anti‑viral immunity during chronic retroviral infectionIn: Retrovirology, Jg. 13, 2016, 24DOI (Open Access)
-
Virus-induced type i interferon deteriorates control of systemic pseudomonas aeruginosa infectionIn: Cellular Physiology and Biochemistry, Jg. 36, 2015, Nr. 6, S. 2379 – 2392DOI (Open Access)
-
Prophylactic and therapeutic vaccination with a nanoparticle-based peptide vaccine induces efficient protective immunity during acute and chronic retroviral infectionIn: Nanomedicine: Nanotechnology, Biology, and Medicine, Jg. 10, 2014, Nr. 8, S. 1787 – 1798
-
The type of adjuvant strongly influences the T-cell response during nanoparticle-based immunizationIn: Human Vaccines & Immunotherapeutics, Jg. 10, 2014, Nr. 1, S. 164 – 169DOI, Online Volltext (Open Access)
-
Immunization with biodegradable nanoparticles efficiently induces cellular immunity and protects against influenza virus infectionIn: The Journal of Immunology (JI), Jg. 190, 2013, Nr. 12, S. 6221 – 6229DOI (Open Access)
-
Mechanism of the uptake of cationic and anionic calcium phosphate nanoparticles by cellsIn: Acta Biomaterialia, Jg. 9, 2013, Nr. 7, S. 7527 – 7535
-
Calcium phosphate nanoparticles as versatile carrier for small and large molecules across cell membranesIn: Journal of Nanoparticle Research, Jg. 14, 2012, Nr. 6, 0910
-
Cell targeting by antibody-functionalized calcium phosphate nanoparticlesIn: Journal of Materials Chemistry, Jg. 22, 2012, Nr. 2, S. 396 – 404
-
CD8+ T-Cell Response Promotes Evolution of Hepatitis C Virus Nonstructural ProteinsIn: Gastroenterology, Jg. 140, 2011, Nr. 7, S. 2064 – 2073
-
Generation and function of immunosuppressive human and murine CD8⁺ T cells by transforming growth factor-β and retinoic acidIn: Immunology, Jg. 134, 2011, Nr. 1, S. 82 – 92DOI (Open Access)
-
Quantitative determination of the composition of multi-shell calcium phosphate-oligonucleotide nanoparticles and their application for the activation of dendritic cellsIn: Acta Biomaterialia, Jg. 7, 2011, Nr. 11, S. 4029 – 4036
-
The use of calcium phosphate nanoparticles encapsulating toll-like receptor ligands and the antigen hemagglutinin to induce dendritic cell maturation and T cell activationIn: Biomaterials, Jg. 31, 2010, Nr. 21, S. 5627 – 5633
-
Session 5: Biomaterials - Inorganic : Calcium phosphate nanoparticles as a delivery of bioactive compounds to the liver and for imaging and vaccination
Annual Conference of the German Society for Biomaterials e.V., 08,-10.11.2018, Braunschweig-Stöckheim,In: Biomedical engineering = Biomedizinische Technik. Berlin; Berlin1: de Gruyter, Jg. 64, 2019, Nr. s1: Abstracts of the 2018 Annual Meeting of the German Society for Biomaterials, S. 36 – 40DOI (Open Access) -
Prophylaktische Vakzinierung gegen Tumoren mit funktionalisierten Calciumphosphat-Nanopartikeln in einem murinen Tumortransplantations- Modell
Annual conference of the German Society of Biomaterials (DGBM) , 06.-08.11.2014, Dresden,In: BioNanoMaterials. Berlin: De Gruyter, Jg. 15, 2014, Nr. Supplement, V5 -
Effective immunmodulation by biodegradable calcium phosphate nanoparticles confers strong antiviral protection
65th Annual Meeting of the German Society for Hygiene and Microbiology (DGHM), 22.-25.09.2013, Rostock,In: International Journal of Medical Microbiology (IJMM). Amsterdam: Elsevier, Jg. 303, 2013, Nr. Suppl. 1, S. 38 – 38 -
703 Evidence for differential adaptation of Hepatitis C virus in populations with different HLA-class i-backgroundIn: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 52, 2010, Nr. Suppl. 1, S. S273
-
Etablierung und Charakterisierung von biodegradierbaren Calciumphosphat Nanopartikeln zur Induktion potenter anti-viraler T-ZellantwortenDuisburg, Essen, 2012
-
Effektive Immunmodulation durch therapeutischeVakzinierung mithilfe von Calcium PhosphatNanopartikelnDuisburg ; Essen, 2024
-
Respiratory but not systemic viral infection induces tumour growth inhibition through CD8+T-cell activation
Joint Conference of the Société Française d'Immunologie (SFI) and the Deutsche Gesellschaft für Immunologie (DGfI) ; 26-29 September, 2023, Strasbourg, France,In: European Journal of Immunology. Hoboken: Wiley, Jg. 53, 2023, Nr. S2, Special issue: Abstracts: Joint Conference of the Société Française d'Immunologie (SFI) and the Deutsche Gesellschaft für Immunologie (DGfI), 26–29 September, 2023, Strasbourg, France, S. 189DOI (Open Access)